Dose-response relationship for breast cancer induction at radiotherapy dose
Open Access
- 8 June 2011
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 67
Abstract
Cancer induction after radiation therapy is known as a severe side effect. It is therefore of interest to predict the probability of second cancer appearance for the patient to be treated including breast cancer. In this work a dose-response relationship for breast cancer is derived based on(i) the analysis of breast cancer induction after Hodgkin's disease,(ii) a cancer risk model developed for high doses including fractionation based on the linear quadratic model, and(iii) the reconstruction of treatment plans for Hodgkin's patients treated with radiotherapy,(iv) the breast cancer induction of the A-bomb survivor data. The fitted model parameters for an α/β = 3 Gy were α = 0.067Gy-1 and R = 0.62. The risk for breast cancer is according to this model for small doses consistent with the finding of the A-bomb survivors, has a maximum at doses of around 20 Gy and drops off only slightly at larger doses. The predicted EAR for breast cancer after radiotherapy of Hodgkin's disease is 11.7/10000PY which can be compared to the findings of several epidemiological studies where EAR for breast cancer varies between 10.5 and 29.4/10000PY. The model was used to predict the impact of the reduction of radiation volume on breast cancer risk. It was estimated that mantle field irradiation is associated with a 3.2-fold increased risk compared with mediastinal irradiation alone, which is in agreement with a published value of 2.7. It was also shown that the modelled age dependency of breast cancer risk is in satisfying agreement with published data. The dose-response relationship obtained in this report can be used for the prediction of radiation induced secondary breast cancer of radiotherapy patients.Keywords
This publication has 20 references indexed in Scilit:
- Dose-response relationship for lung cancer induction at radiotherapy doseZeitschrift für Medizinische Physik, 2010
- Breast Cancer Risk in Female Survivors of Hodgkin's Lymphoma: Lower Risk After Smaller Radiation VolumesJournal of Clinical Oncology, 2009
- Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2009
- Frequency Distribution of Second Solid Cancer Locations in Relation to the Irradiated Volume Among 115 Patients Treated for Childhood CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer riskRadiation Oncology, 2007
- Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998Radiation Research, 2007
- Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent doseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin DiseaseJAMA, 2003
- Second Primary Tumors after Radiotherapy for MalignanciesStrahlentherapie und Onkologie, 2002
- Long-term complications of treatment and causes of mortality after Hodgkin's diseaseSeminars in Radiation Oncology, 1996